Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Files $20M Shelf Registration

NEW YORK (GenomeWeb) – Response Genetics has filed a shelf registration with the US Securities and Exchange Commission to offer up to $20 million in securities from time to time.

Securities that may be offered include Response's common stock, preferred stock, and warrants, the company said in its SEC document. Proceeds from any offering will go toward general corporate purposes, such as the funding of its operations, working capital, R&D efforts, capital expenditures, and strategic investments.

In December, Response launched a $4.8 million public offering of its common stock.

Late last month, the Los Angeles-based molecular diagnostics firm said that it received a warning letter from the Nasdaq that its shares had closed below a minimum $1 per share for 30 consecutive business day, putting Response in jeopardy of having its stock delisted from the Nasdaq Capital Market. The firm has until Dec. 17 to regain compliance.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.